Tirzepatide
Tirzepatide image 1Tirzepatide image 2
Metabolic ResearchStandardReport Available

Tirzepatide

Research overview

UWA Biotech Tirzepatide with verified testing, 5mg to 60mg options and wholesale metabolic research supply.

Purity99.688%
Format5mg
Ships FromUnited States
MOQ10 vials / 1 box

Available variants

10 × 5mg$70.00In Stock
10 × 10mg$90.00In Stock
10 × 15mg$125.00In Stock
10 × 20mg$155.00In Stock
10 × 30mg$185.00In Stock
10 × 60mg$300.00In Stock

Product description

Product overview

Tirzepatide is a dual GIP and GLP-1 pathway research peptide supplied by UWA Biotech for laboratory investigations involving metabolic signalling, incretin receptor activity, peptide pharmacology and advanced obesity and metabolic research applications.

Available formats

  • 10 × 5mg
  • 10 × 10mg
  • 10 × 15mg
  • 10 × 20mg
  • 10 × 30mg
  • 10 × 60mg
  • MOQ: 10 vials / 1 box

Verification

  • Purity: 99.688%
  • Tested: 25 FEB 2026
  • Task number: #110143
  • Unique key: 5IVMYW1E5G18

Research applications

  • GLP-1 pathway research
  • GIP receptor investigations
  • Metabolic signalling studies
  • Incretin peptide research
Research use only

This product is supplied exclusively for laboratory research use. Not for human consumption, therapeutic use or clinical application.

Verification report

Report typeJanoshik / COA
Task number#110143
Unique ID5IVMYW1E5G18
Tested25 FEB 2026
Open reportTirzepatide COA